Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Europe Pirfenidone Market Report 2016

By QYResearch Group
"...... e countries, with sales, price, revenue and market share for each player in these Countries, covering - Genentech (Roche) - Shionogi - GNI Group - Beijing Continent - Cipla Market Segment by Countries......"
29-Nov-2016$3900

Ventilator Associated Pneumonia (VAP)-Pipeline Insights, 2016

By Delve Insight
"...... lopment including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fu......"
01-Nov-2016$1250

Tiotropium -Drug Insights, 2016

By Delve Insight
"...... lso provides the Tiotropium sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tiotropium, patents information and exclusivity data, route of synthesis, co......"
01-Nov-2016$1000

Emphysema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... rstand the market and pipeline status of the drugs around the Emphysema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides t......"
01-Nov-2016$2000

Emphysema-Pipeline Insights, 2016

By Delve Insight
"...... Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Del......"
01-Nov-2016$1250

Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ia Report is to understand the market and pipeline status of the drugs around the Bacterial Pneumonia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The De......"
01-Nov-2016$2000

Berylliosis (Chronic Beryllium Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... he Berylliosis (Chronic Beryllium Disease) Report is to understand the market and pipeline status of the drugs around the Berylliosis (Chronic Beryllium Disease) to explore the generic development opportunities, licensing opportunities and to gain co......"
01-Nov-2016$2000

Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... derstand the market and pipeline status of the drugs around the Bronchitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provide......"
01-Nov-2016$2000

Bacterial Pneumonia-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... d Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Obstructive Pulmonary Disease (COPD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the ......"
01-Nov-2016$4950

Avail upto 50% Discount on below Publisher Reports.